QGEN:NYSE
Qiagen NV
$44.47
arrow_downward
-1.20%(-0.54) 1D
Sep 29, 10:16:47 AM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for QGEN...
Open
$44.08
High
$44.54
Low
$44.04
Mkt. cap
9.18B
Avg. vol.
2.39M
Volume
329.74K
Dividend
0.79%
Quarterly dividend
$0.09
Ex-dividend date
Jul 7, 2026
P/E ratio
22.88
52-wk high
$57.82
52-wk low
$32.53
EPS
$1.94
Beta
0.63
Shares outstanding
206.08M
No. of employees
6K
Open
$44.08
High
$44.54
Low
$44.04
Mkt. cap
9.18B
Avg. vol.
2.39M
Volume
329.74K
Dividend
0.79%
Quarterly dividend
$0.09
Ex-dividend date
Jul 7, 2026
P/E ratio
22.88
52-wk high
$57.82
52-wk low
$32.53
EPS
$1.94
Beta
0.63
Shares outstanding
206.08M
No. of employees
6K
News stories
From web sources and news partners
Yahoo Finance
·
11 hours ago
Qiagen (QGEN), What Is Behind The Fresh Attention Now?
Simply Wall Street
·
21 hours ago
Can Qiagen (QGEN) Look Cheap On Its New FDA Cleared Sepsis Test Push?
AD HOC NEWS
·
1 day ago
Qiagen stock gets a fresh FDA catalyst from QIAstat-Dx
Profile
QIAGEN N.V. is a German-founded multinational provider of sample and assay technologies for molecular diagnostics, applied testing, academic research, and pharmaceutical research. The company operates in more than 35 offices in over 25 countries. QIAGEN N.V., the global corporate headquarter of the QIAGEN group, is located in Venlo, The Netherlands. The main operative headquarters are located in Hilden, Germany. European, American, Chinese, and Asian-Pacific regional headquarters are located respectively in Hilden, Germany; Germantown, Maryland, United States; Shanghai, China; and Singapore. QIAGEN's shares are listed at the NYSE and at the Frankfurt Stock Exchange in the Prime Standard. Thierry Bernard is the company's Chief Executive Officer. Wikipedia
About Qiagen NV
CEOThierry Bernard
Employees5.5K
FoundedNov 29, 1984
HeadquartersVenlo, Limburg, Netherlands
SectorHealth care
Websiteqiagen.com